Faculty Members

Dr. Krishna Murti
Lecturer
Department of Pharmacy Practice

National Institute of Pharmaceutical Education & Research,
(NIPER), Hajipur-844 101, Bihar, India.

Mobile No.: 08969304233
E-mail : krishnamurti74@yahoo.co.in

Educational qualifications:

Ph.D. : Ph.D. in Pharmacology (Pharmaceutical Sciences) from Singhania University, (Rajasthan)

M.Pharm : From Dept. of Pharmacology, College of Pharmaceutical Sciences, Manipal; Manipal Academy of Higher Education in the year 2002.

B. Pharm.: From S. N. Institute of Pharmacy, Pusad (Amravati University, Maharashtra) in the year 1999.

 

Research publications:

Krishna Murti1*, Vijay Lambole, Mayank Panchal, Megha Shah “'Antidiabetic and antihyperlipidemic activity of roots of Matricaria recutita on Streptozotocin-induced diabetic rats” Research Journal of Pharmacology and Pharmacodynamics; 3(4): 2011; 180-183

Krishna Murti*, Mayank A. Panchal, Vijay Lambole “Exploration of healing promoting potentials of roots of Ficus religiosa” Pharmacologia, Vol.12, 2011

Krishna Murti1*, Vijay Lambole1, Mayank Panchal1, Megha Shah1 ”Healing promoting potentials of roots of Scoparia dulcis in albino rats” Pharmacologia, Vol.12, 2011 Mayank Panchal, Biren Shah, Krishna Murti, Megha Shah. Phytochemical investigation and antidiabetic activity studies of Moringa oliefera roots. Research Journal of Pharmacology and Pharmacodynamics; 3(5): 2011; 268-277

Krishna Murti, Upendra Kumar, Manish Kaushik, Aditi Kaushik. 'Pharmacognostical and preliminary phytochemical investigation of roots of Ficus benghalensis'' Asian Journal of Traditional Medicine, 7(1) 2012.
Surabhi Bhatnagar, Shweta, Krishna Murti, Ashok Kumar Gupta, S.K.Sudhakar. Adverse effects of Amphotericin B in patients of Visceral Leishmaniasis: A Short Report at Research Hospital Patna, India. American Journal of Virology 2 (1): 20-24, 2013
M.Arif Khan, R Vinay Kumar, K Pandey, Krishna Murti, Ashok K. Gupta. Epidemiological Survey of Visceral Leishmaniasis: An Evidence Based Report. American Journal of Infectious Diseases 9 (2): 59-62, 2013
Shweta1, Surabhi Bhatnagar, Ashok Kumar Gupta, Krishna Murti, Krishna Pandey. Co-infection of visceral leishmaniasis and pulmonary tuberculosis: a case study. Asian Pac J Trop Dis. 2014; 4(1): 57-60
Anjo Sunny, Gollapalli Rajeev kumar, Santhosh Kumar Sudhakar, Krishna Murti, Ashok Kumar Gupta. Recurrent visceral leishmaniasis in a HIV positive patient—a case report. Journal of Coastal Life Medicine 2014; 2(1): 46-48
Arif Khan, M., Raj Kishore Pandey, Tarique Nadeem, Manoj Kumar Sethi, Sumit Sharma, Krishna Murti, Ashok Gupta and Krishna Pandey. Complicated Case of Rheumatic Heart Disease; Unexplored for Years. OnLine Journal of Biological Sciences 14 (1): 44-48, 2014
Krishna Pandey, Dharmendra Singh, Sanjiva Bimal, Krishna Murti, and Pradeep Das2. Association of Testosterone and Cholesterol level in Modulation of Immunity and Severity of Disease in Visceral Leishmaniasis Patients- A Preliminary study. American Journal of Immunology, 2014 March. Science Publication.
Vidyanand Rabi Das, Dharmendra Singh, Krishna Murti, Sushmita Das, Pradeep Das, and Krishna Pandey. Post-kala-azar Dermal Leishmaniasis with Ulceration on foot: An atypical case presentation successfully treated with Miltefosine. American Journal of Infectious Disease. 2014. Science Publication.
Krishna Pandey, Dharmendra Singh, Sanjiva Bimal, Vidyanand Rabidas, Krishna Murti, Chadrashekhar Lal and P. Das. Newer Drugs for Visceral Leishmaniasis: A Review. American Journal of Infectious Diseases 10 (2): 68-70, 2014.
Manoj Kumar Sethi, Mohammad Arif Khan, Krishna Murti, Dharmendra Singh, P. Das, Krishna Pandey: Co-Infection of Neurocysticercosis and Intracranial Tuberculoma: A Rare Case. International Journal of Pharmaceutical Science and Health Care. Issue 4, Vol. 3.May-June 2014
Manoj Kumar Sethi, Dharmendra Singh, Krishna Murti, Shailendra S. Chaudhaery, Krishna Pandey, Pradeep Das. DPP-4 inhibitors: A novel approach for management of type-2 diabetes mellitus. World Journal of Pharmaceutical Sciences, 2014; 2(10): 1395-1400
M.Arif Khan, Krishna Murti, Vaibhav Grover, Kanhaya Lal, Dharmendra Singh, P. Das, Krishna Pandey. Atorvastatin Vs Rousuvastatin: Fenofibrate As AN Add On: An Exploratory Study. International Journal of Pharmacy & Pharmaceutical Sciences. 6(8):1-6, 2014.

A. Nath, Rahul Kumar, Vinita Trivedi, Krishna Murti, Shailendra Kumar, Chandan Kumar Singh, J.K.Singh, P.Das. MDA Elevation and Haematological Derangements at First Clinical Presentation in Cervical Cancer Patients. Int. J. Pharm. Sci. Rev. Res., 30(2), 175-179. 2015.

A. Nath, Sanjesh Kumar, Manisha Singh, MD. Tarique Nadeem, Krishna Murti, A.K. Gupta, P. Das, Priyanka & Aseem Kumar. Combined Assessment of Lipid Peroxidation, CEA and CA19.9
Bio-Markers in Advanced Stage Gall Bladder Cancer. International Journal of Recent Scientific Research, Accepted. 2015.
Krishna Murti, M. Arif Khan, Akalanka Dey, Manoj Kumar Sethi, Pradeep Das and Krishna Pandey Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines. American Journal of Pharmacology & Toxicology. 10 (1), 27-31, 2015
Krishna Murti, Manoj Kumar Sethi, Akalanka Dey, Pradeep Das, Chandra Sekhar Lal, Krishna Pandey. Addition of Voglibose to Glimepiride & Metformin have better Glucose Control in Diabetics. A Prospective, Parallel-Group, Open-Label Comparative Study. International Journal of Pharmacology. 12 (4): 422-428, 2016. Impact Factor: 1.503. ISI Thomson Reuters)

Rahul Kumar, Vinita Trivedi, Krishna Murti*, Akalanka Dey, Jitendra Kumar Singh, A Nath, P Das. Arsenic Exposure and Haematological Derangement in Cervical Cancer Cases in India. Asian Pacific Journal of Cancer Prevention. DOI: http://dx.doi.org/10.7314/APJCP.2015.16.15.6397 (Impact Factor: 2.51, ISI Thomson Reuters)

 
     
 
     
   
       
 
ABOUT US
Introduction
About Hajipur
Niper Act
RTI
RMRIMS Mentor Institute
Events & Seminar
Photo Gallery
ACADEMIC
Academic Program & Departments
Academic Calendar
Examination
Publication
Student & Alumni
OUR TEAM
Faculty Members
Administrative Team
 
ANNOUNCEMENT
Career
Tenders
DIRECTOR'S DESK
FACILITY
PLACEMENT CELL
CONTACT US
HOME